Viewing Study NCT06078306


Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2026-06-14 @ 4:20 PM
Study NCT ID: NCT06078306
Status: UNKNOWN
Last Update Posted: 2024-04-22
First Post: 2023-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Acute Lymphoblastic Leukemia View
None Ph-Negative ALL View
None High Risk Acute Lymphoblastic Leukemia View
Keywords: